U.S. Markets close in 37 mins

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
30.90-1.75 (-5.35%)
As of 03:20PM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 343.26
52 Week Low 314.89
50-Day Moving Average 333.76
200-Day Moving Average 328.18

Share Statistics

Avg Vol (3 month) 3257.54k
Avg Vol (10 day) 3181.02k
Shares Outstanding 529.37M
Implied Shares Outstanding 6N/A
Float 820.59M
% Held by Insiders 12.50%
% Held by Institutions 189.76%
Shares Short (Jul 29, 2021) 41.6M
Short Ratio (Jul 29, 2021) 45.82
Short % of Float (Jul 29, 2021) 47.55%
Short % of Shares Outstanding (Jul 29, 2021) 45.45%
Shares Short (prior month Jun 29, 2021) 41.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,225.52%

Management Effectiveness

Return on Assets (ttm)-20.33%
Return on Equity (ttm)-35.27%

Income Statement

Revenue (ttm)4.92M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)-31.90%
Gross Profit (ttm)5.04M
EBITDA -59.24M
Net Income Avi to Common (ttm)-59.99M
Diluted EPS (ttm)-2.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)223.3M
Total Cash Per Share (mrq)7.57
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)21.93
Book Value Per Share (mrq)3.69

Cash Flow Statement

Operating Cash Flow (ttm)-53.15M
Levered Free Cash Flow (ttm)-31.29M